MedTrace Logo

A Clinical Investigation to Evaluate The Orkla Corn Plaster

NCT04601259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2021-09-09

No results posted yet for this study

Summary

This is a prospective, randomized, controlled, open-labelled investigation to assess performance and safety of Orkla Corn Plaster in subject with corns. The hypothesis is that there is an improvement in the size of corns at day 28 compared to baseline.

Conditions

  • Corns

Interventions

COMBINATION_PRODUCT

Orkla Corn Plaster with salicylic acid

Each participating subject will receive Orkla Corn Plasters for usage up to 28 days, or until corn resolution whichever comes first. Subjects will be instructed to change plasters daily.

DEVICE

Orkla Corn Protector

Each participating subject will receive Orkla Corn Protector for usage up to 28 days, or until corn resolution whichever comes first. Subjects will be instructed to change plasters daily.

Sponsors & Collaborators

  • Orkla Care AB

    lead INDUSTRY

Principal Investigators

  • Felix Lundin · Carlanderska Hospital, Carlandersparken 1, 405 45 Göteborg, Sweden.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-21
Primary Completion
2021-01-14
Completion
2021-06-10

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04601259 on ClinicalTrials.gov